Multiple inflammatory markers in patients with significant coronary artery disease
Authors:
- Vibeke VidemVVVibeke Videm
- Rune WisethRWRune Wiseth
- Sigurd GunnesSGSigurd Gunnes
- Hans O. MadsenHMHans O. Madsen
- Peter GarredPGPeter Garred
- 1 May 2007
- journal article
- Published by Elsevier in International Journal of Cardiology
- Vol. 118 (1) , 81-87
Abstract
No abstract availableKeywords
Funding Information
- Novo Nordisk UK Research Foundation
- Helse Midt-Norge
- Sundhed og Sygdom, Det Frie Forskningsråd
- EkstraStiftelsen Helse og Rehabilitering
This publication has 23 references indexed in Scilit:
- The failure of antibiotics to prevent heart attacksBMJ, 2005
- Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosisEuropean Heart Journal, 2005
- Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive proteinInternational Journal of Cardiology, 2005
- Hereditary C2 Deficiency in SwedenMedicine, 2005
- Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-κBCellular Immunology, 2002
- Inflammation and AtherosclerosisCirculation, 2002
- Human Lactoferrin Interacts with Soluble CD14 and Inhibits Expression of Endothelial Adhesion Molecules, E-Selectin and ICAM-1, Induced by the CD14-Lipopolysaccharide ComplexInfection and Immunity, 2000
- Circulating Vascular Cell Adhesion Molecule-1 Correlates With the Extent of Human Atherosclerosis in Contrast to Circulating Intercellular Adhesion Molecule-1, E-Selectin, P-Selectin, and ThrombomodulinArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Heparin in Clinical Doses ‘Primes’ Granulocytes to Subsequent Activation as Measured by Myeloperoxidase ReleaseScandinavian Journal of Immunology, 1996
- An enzyme linked immunosorbent assay for measurements of lactoferrin in duodenal aspirates and other biological fluidsScandinavian Journal of Clinical and Laboratory Investigation, 1985